Espindolol
CAS No. 26328-11-0
Espindolol ( AGI-001; MT-102; AGI001; MT102; AGI 001; MT 102 )
Catalog No. M27876 CAS No. 26328-11-0
Espindolol is a novel non-selective β blocker with central 5-HT1a and partial β2 receptor agonist effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 210 | Get Quote |
|
10MG | 302 | Get Quote |
|
25MG | 608 | Get Quote |
|
50MG | 913 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEspindolol
-
NoteResearch use only, not for human use.
-
Brief DescriptionEspindolol is a novel non-selective β blocker with central 5-HT1a and partial β2 receptor agonist effects.
-
DescriptionEspindolol is a novel non-selective β blocker with central 5-HT1a and partial β2 receptor agonist effects.(In Vivo):Placebo-treated rats progressively lost body weight (-15.5 ± 7.2 g), lean mass (-1.5 ± 4.2 g), and fat mass (-15.6 ± 2.7 g), while espindolol treatment increased body weight (+8.0 ± 6.1 g, p < 0.05), particularly lean mass (+43.4 ± 3.5 g, p < 0.001), and reduced fat mass further (-38.6 ± 3.4 g, p < 0.001). Anabolic/catabolic signaling was assessed in gastrocnemius muscle. Espindolol decreased proteasome and caspase-3 proteolytic activities by approximately 50 % (all p < 0.05).
-
SynonymsAGI-001; MT-102; AGI001; MT102; AGI 001; MT 102
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number26328-11-0
-
Formula Weight248.3
-
Molecular FormulaC14H20N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)NC[C@H](O)COc1cccc2[nH]ccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fujimoto Y, et al. Fixed drug eruption due to allylisopropylacetylurea. Contact Dermatitis. 1993 May;28(5):282-4.
molnova catalog
related products
-
Alosetron hydrochlor...
A potent and selective 5-HT3 receptor antagonist has been shown to be beneficial in the treatment of irritable bowel syndrome.
-
Thioridazine hydroch...
Thioridazine is an antipsychotic drug, used in the treatment of schizophrenia and psychosis, shows D4 selectivity or serotonin antagonism.
-
XL888
XL888 is an ATP-competitive inhibitor of Hsp90 ( IC50: 24 nM). Heat shock protein 90 (Hsp90) is a chaperone that maintains the functionality of client proteins involved in cell proliferation, cell cycling, and apoptosis.